A股異動 | 嘉友國際漲9%股價創歷史新高 上半年淨利同比預增70%-90%
格隆匯7月1日丨嘉友國際(603871.SH)盤中漲9.58%,報18.52元,總市值82億元,股價創歷史新高。公司6月30日晚間披露業績預吿,預計2022年半年度淨利潤2.67億元到2.98億元,與上年同期相比,將增加1.1億元到1.41億元,同比增加70%到90%。隨着新冠肺炎疫情影響逐步降低,中蒙陸路邊境口岸逐步恢復正常,蒙煤通關量持續回升,公司主焦煤供應鏈貿易業務較上年同期增長顯著;公司投資建設的非洲剛果(金)卡松巴萊薩-薩卡尼亞道路與陸港的現代化與改造項目的道路開通試運營,公司業務由跨境物流延伸至公路運營,收費公路成為公司新的業績增長點。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.